المؤلفون: Dubuisson, Jean, François-Loïc, Cosset

المساهمون: Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 (CIIL), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille)-Centre National de la Recherche Scientifique (CNRS), Virus enveloppés, vecteurs et immunothérapie – Enveloped viruses, Vectors and Immuno-therapy CIRI (EVIR), Centre International de Recherche en Infectiologie (CIRI), École normale supérieure de Lyon (ENS de Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-École normale supérieure de Lyon (ENS de Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Work in the JD laboratory was supported by the French National Agency for Research on AIDS and Viral Hepatitis (ANRS) and ANR through ERA-NET Infect-ERA program (ANR-13-IFEC-0002-01). Work in the FLC laboratory was supported by ANRS, the European Research Council (ERC-2008-AdG-233130-HEPCENT) and the LabEx ECOFECT (ANR-11-LABX-0048) of Université de Lyon., We thank Laurence Cocquerel and Marlène Dreux for critical reading of the manuscript and Sophana Ung for help with the Figures. We apologize to all colleagues whose work could not be referenced because of length restriction.

المصدر: ISSN: 0168-8278.

مصطلحات موضوعية: Hepatitis C virus, Viral life cycle, Virus entry, Virus-host interactions, MESH: Cell Biology/trends, MESH: Hepacivirus/genetics, MESH: Hepacivirus/growth & development, MESH: Hepacivirus/pathogenicity, MESH: Hepatitis C/pathology, MESH: Hepatitis C/physiopathology, MESH: Hepatocytes/pathology, MESH: Hepatocytes/virology, MESH: Humans, MESH: Life Cycle Stages/physiology, MESH: Lipid Metabolism/physiology, MESH: RNA, Viral/physiology, MESH: Virology/trends, MESH: Virus Replication/physiology, [SDV]Life Sciences [q-bio], [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

Relation: info:eu-repo/semantics/altIdentifier/pmid/25443344; hal-01140479; https://hal.science/hal-01140479; https://hal.science/hal-01140479/document; https://hal.science/hal-01140479/file/1-s2.0-S0168827814004619-main.pdf; PUBMED: 25443344

الاتاحة: https://hal.science/hal-01140479
https://hal.science/hal-01140479/document
https://hal.science/hal-01140479/file/1-s2.0-S0168827814004619-main.pdf
https://doi.org/10.1016/j.jhep.2014.06.031

المؤلفون: Matthew L. Albert, Yoann Barthe, Armanda Casrouge, Arnaud Fontanet, Stanislas Pol, Sylvie Lagaye, Hélène Fontaine, Vincent Mallet, Philippe Sultanik, Christophe Hézode, Estelle Mottez, Laurent Abel, Etienne Gayat, Céline Dorival, Fabrice Carrat, Jean-Pierre Bronowicki, Ioannis Theodorou

المساهمون: Institut Cochin (IC UM3 (UMR 8104 / U1016)), Centre National de la Recherche Scientifique (CNRS)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Département d'hépatologie, Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Immunobiologie des Cellules Dendritiques, Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), Epidémiologie, systèmes d'information, modélisation, Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Departement d'Hépatho-Gastro-Enterologie [Mondor], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Centre Hospitalier Universitaire Henri Mondor, Centre d'Immunologie Humaine (CIH), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Nutrition-Génétique et Exposition aux Risques Environnementaux (NGERE), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Service de santé publique [CHU Saint-Antoine], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Immunité et Infection, Université Pierre et Marie Curie - Paris 6 (UPMC)-IFR113-Institut National de la Santé et de la Recherche Médicale (INSERM), Imagine - Institut des maladies génétiques (IMAGINE - U1163), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Laboratory of Human Genetics of Infectious Diseases, Rockefeller University [New York]-Rockefeller Branch, Biomarqueurs CArdioNeuroVASCulaires (BioCANVAS), Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), Department of anesthesiology and critical care medicine, Hôpitaux Universitaire Saint-Louis, Lariboisière, Fernand-Widal, Département Infection et Epidémiologie - Department of Infection and Epidemiology, Institut Pasteur [Paris], The CUPIC Cohort study was sponsored and funded by The National Agency for research on Aids and Viral Hepatitis (ANRS), with support by the French Association for the Study of the Liver(AFEF). The authors also wish to acknowledge the Center for Human Immunology for its support of the research project., Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institut Pasteur [Paris] (IP), CHU Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Centre Hospitalier Universitaire Henri Mondor, Université de Lorraine (UL)-Institut National de la Santé et de la Recherche Médicale (INSERM), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-CHU Saint-Antoine [APHP], Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR113-Université Pierre et Marie Curie - Paris 6 (UPMC), Rockefeller Branch-rockefeller university, Institut Cochin ( UM3 (UMR 8104 / U1016) ), Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ), Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale ( INSERM ), Université Pierre et Marie Curie - Paris 6 ( UPMC ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Assistance publique - Hôpitaux de Paris (AP-HP)-Centre Hospitalier Universitaire Henri Mondor, Centre d'Immunologie Humaine ( CIH ), Centre Hospitalier Régional Universitaire de Nancy ( CHRU Nancy ), Assistance publique - Hôpitaux de Paris (AP-HP)-CHU Saint-Antoine [APHP], Institut National de la Santé et de la Recherche Médicale ( INSERM ) -IFR113-Université Pierre et Marie Curie - Paris 6 ( UPMC ), Imagine - Institut des maladies génétiques ( IMAGINE - U1163 ), Centre National de la Recherche Scientifique ( CNRS ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Université Paris Descartes - Paris 5 ( UPD5 ), Biomarqueurs CArdioNeuroVASCulaires ( BioCANVAS ), Université Paris Diderot - Paris 7 ( UPD7 ) -Université Paris 13 ( UP13 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Département Infection et Epidémiologie

المصدر: Liver International
Liver International, Wiley-Blackwell, 2015, 35 (7), pp.1833-1844. ⟨10.1111/liv.12759⟩
Liver International, 2015, 35 (7), pp.1833-1844. ⟨10.1111/liv.12759⟩
Liver International, Wiley-Blackwell, 2015, 35 (7), pp.1833-1844. 〈10.1111/liv.12759〉

مصطلحات موضوعية: Male, MESH : Aged, MESH : Prospective Studies, MESH : Viral Load, MESH : Hepatitis C, Chronic/blood, Hepacivirus, MESH : Virus Replication/drug effects, Polyethylene Glycols, MESH: Molecular Targeted Therapy, [ SDV.IMM ] Life Sciences [q-bio]/Immunology, Molecular Targeted Therapy, Prospective Studies, MESH: Ribavirin/therapeutic use, MESH : Proline/analogs & derivatives, MESH: Treatment Outcome, MESH : Hepacivirus/drug effects, MESH: Viral Nonstructural Proteins/metabolism, MESH: Middle Aged, MESH: RNA, Viral/blood, virus diseases, MESH : beta 2-Glycoprotein I/blood, Blood proteins, 3. Good health, beta 2-Glycoprotein I, Area Under Curve, MESH: Hepacivirus/genetics, Drug Therapy, Combination, Oligopeptides, Apolipoprotein H, MESH : Biomarkers/blood, MESH: Hepatitis C, Chronic/drug therapy, Proline, MESH: Hepatitis C, Chronic/blood, virological response, MESH: Proline/analogs & derivatives, MESH : Antiviral Agents/therapeutic use, Antiviral Agents, MESH : Proline/therapeutic use, Boceprevir, MESH : Recombinant Proteins/therapeutic use, Humans, chronic hepatitis C, MESH : Middle Aged, Protease Inhibitors, MESH: Interferon-alpha/therapeutic use, MESH : Predictive Value of Tests, Aged, MESH: Polyethylene Glycols/therapeutic use, MESH : Hepacivirus/genetics, MESH: Humans, Surrogate endpoint, MESH : Humans, MESH: beta 2-Glycoprotein I/blood, MESH: ROC Curve, digestive system diseases, chemistry, MESH: Protease Inhibitors/therapeutic use, Immunology, MESH: Female, Biomarkers, Time Factors, MESH : Viral Nonstructural Proteins/antagonists & inhibitors, MESH : Hepatitis C, Chronic/diagnosis, MESH : Protease Inhibitors/therapeutic use, Viral Nonstructural Proteins, Virus Replication, MESH : Polyethylene Glycols/therapeutic use, HCV protease inhibitor, Telaprevir, MESH: Virus Replication/drug effects, MESH: Proline/therapeutic use, chemistry.chemical_compound, apolipoprotein H, MESH: Hepacivirus/drug effects, MESH : RNA, Viral/blood, MESH : Female, MESH: Hepatitis C, Chronic/diagnosis, MESH : Viral Nonstructural Proteins/metabolism, MESH: Aged, Middle Aged, Viral Load, MESH: Hepacivirus/growth & development, Recombinant Proteins, MESH: Predictive Value of Tests, MESH : Hepacivirus/enzymology, Treatment Outcome, RNA, Viral, biomarker, [SDV.IMM]Life Sciences [q-bio]/Immunology, Biomarker (medicine), Female, France, MESH: Viral Load, MESH : Oligopeptides/therapeutic use, MESH : Time Factors, medicine.drug, MESH : Hepatitis C, Chronic/drug therapy, MESH : Molecular Targeted Therapy, MESH: Biomarkers/blood, MESH: Hepacivirus/enzymology, MESH : Male, MESH : Ribavirin/therapeutic use, MESH : Interferon-alpha/therapeutic use, MESH : Treatment Outcome, Biology, Predictive Value of Tests, MESH: Recombinant Proteins/therapeutic use, Ribavirin, medicine, MESH : France, NS3, MESH: Viral Nonstructural Proteins/antagonists & inhibitors, Hepatology, MESH : Drug Therapy, Combination, MESH: Time Factors, Interferon-alpha, Hepatitis C, Chronic, MESH : Hepacivirus/growth & development, MESH: Male, MESH: Prospective Studies, MESH: France, MESH: Drug Therapy, Combination, ROC Curve, MESH: Antiviral Agents/therapeutic use, MESH: Oligopeptides/therapeutic use, MESH: Area Under Curve, MESH : Area Under Curve, MESH : ROC Curve

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90633f842d8de6ea3f7f4df0ad3c882d
https://doi.org/10.1111/liv.12759

المؤلفون: Chapel, Cynthia, Garcia, Céline, N., Roingeard, Philippe, Zitzmann, Nicole, Dubuisson, Jean, Dwek, Raymond, Trépo, Christian, Zoulim, Fabien, Durantel, David

المساهمون: Virus des hépatites et pathologies associées, Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM), Morphogénèse et antigénicité du VIH, des Virus des Hépatites et Emergents (MAVIVHe), Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM), Virus, pseudo-virus: Morphogénèse et Antigénicité, Université de Tours (UT)-EA3856, Oxford Glycobiology Institute, University of Oxford, Institut de biologie de Lille - IBL (IBLI), Université de Lille, Sciences et Technologies-Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Université de Lille, Droit et Santé-Centre National de la Recherche Scientifique (CNRS), Assemblage et réplication du virus de l'hépatite C (ARVHC), Centre National de la Recherche Scientifique (CNRS), C. C. and D. D. were supported by the French National Agency for AIDS and Viral Hepatitis Research (ANRS). This work was supported by INSERM, the French National Agency for AIDS and Viral Hepatitis Research (ANRS) and the European Community (ViRgil LSHM-CT-2004-503359). N. Z. is supported by the Oxford Glycobiology Institute Endowment., We thank Dr Jo O'Leary for careful reading of the manuscript.

المصدر: ISSN: 0022-1317.

مصطلحات موضوعية: MESH: Animals, MESH: Antiviral Agents/pharmacology, MESH: Glycosylation, MESH: Hepacivirus*/drug effects, MESH: Hepacivirus*/pathogenicity, MESH: Hepacivirus*/growth & development, MESH: Humans, MESH: Morphogenesis/drug effects, MESH: Spodoptera, MESH: Viral Envelope Proteins/chemistry, MESH: Viral Envelope Proteins/genetics, MESH: Viral Envelope Proteins/metabolism, MESH: Viral Structural Proteins/metabolism, MESH: Viral Structural Proteins/genetics, MESH: Virion/drug effects, MESH: Baculoviridae, MESH: Virion/metabolism, MESH: Cell Line, Tumor, MESH: Cells, Cultured, MESH: Enzyme Inhibitors/pharmacology, MESH: Glycoside Hydrolase Inhibitors, [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology

Relation: info:eu-repo/semantics/altIdentifier/pmid/16528036; hal-00105496; https://hal.science/hal-00105496; PUBMED: 16528036

الاتاحة: https://hal.science/hal-00105496
https://doi.org/10.1099/vir.0.81503-0

المؤلفون: Christian Trepo, Nicole Zitzmann, Raymond A. Dwek, C Chapel, Fabien Zoulim, Philippe Roingeard, Jean Dubuisson, David Durantel, C Garcia

المساهمون: Virus des hépatites et pathologies associées, Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM), Morphogénèse et antigénicité du VIH et du virus des Hépatites (MAVIVH - U1259 Inserm - CHRU Tours ), Centre Hospitalier Régional Universitaire de Tours (CHRU TOURS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Tours, Virus, pseudo-virus: Morphogénèse et Antigénicité, Université de Tours-EA3856, Oxford Glycobiology Institute, University of Oxford [Oxford], Institut de biologie de Lille - IBL (IBLI), Université de Lille, Sciences et Technologies-Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Centre National de la Recherche Scientifique (CNRS)-Université de Lille, Droit et Santé, Assemblage et réplication du virus de l'hépatite C (ARVHC), Centre National de la Recherche Scientifique (CNRS), C. C. and D. D. were supported by the French National Agency for AIDS and Viral Hepatitis Research (ANRS). This work was supported by INSERM, the French National Agency for AIDS and Viral Hepatitis Research (ANRS) and the European Community (ViRgil LSHM-CT-2004-503359). N. Z. is supported by the Oxford Glycobiology Institute Endowment., We thank Dr Jo O'Leary for careful reading of the manuscript., Centre Hospitalier Régional Universitaire de Tours (CHRU Tours)-Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Tours (UT)-EA3856

المصدر: Journal of General Virology
Journal of General Virology, Microbiology Society, 2006, 87, pp.861-871. ⟨10.1099/vir.0.81503-0⟩

مصطلحات موضوعية: Glycosylation, Hepacivirus, viruses, MESH: Antiviral Agents/pharmacology, medicine.disease_cause, MESH: Viral Structural Proteins/genetics, 0302 clinical medicine, Virus-like particle, Viral Envelope Proteins, Morphogenesis, MESH: Animals, MESH: Hepacivirus*/drug effects, Enzyme Inhibitors, MESH: Morphogenesis/drug effects, Cells, Cultured, chemistry.chemical_classification, 0303 health sciences, MESH: Spodoptera, biology, virus diseases, MESH: Viral Envelope Proteins/metabolism, MESH: Glycosylation, 3. Good health, MESH: Hepacivirus*/growth & development, MESH: Virion/drug effects, MESH: Baculoviridae, [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology, MESH: Viral Envelope Proteins/genetics, 030211 gastroenterology & hepatology, Baculoviridae, MESH: Cells, Cultured, MESH: Viral Envelope Proteins/chemistry, MESH: Cell Line, Tumor, MESH: Viral Structural Proteins/metabolism, MESH: Glycoside Hydrolase Inhibitors, Hepatitis C virus, MESH: Hepacivirus*/pathogenicity, Spodoptera, Antiviral Agents, Virus, 03 medical and health sciences, MESH: Virion/metabolism, Virology, Calnexin, Cell Line, Tumor, medicine, Animals, Humans, Glycoside Hydrolase Inhibitors, 030304 developmental biology, Viral Structural Proteins, MESH: Humans, Endoplasmic reticulum, Virion, biology.organism_classification, MESH: Enzyme Inhibitors/pharmacology, chemistry, Cell culture, Glycoprotein

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8bfdeb5ee4b726800c187bb52ad37ce
http://ora.ox.ac.uk/objects/uuid:8e47963b-28b4-4712-8d4a-4607d03d258d